Nemaura Medical Inc
OTC:NMRD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Y
|
Yantai Eddie Precision Machinery Co Ltd
SSE:603638
|
CN |
|
Card Factory PLC
LSE:CARD
|
UK |
|
G
|
Gildan Activewear Inc
NYSE:GIL
|
CA |
|
G
|
Gibo Holdings Ltd
NASDAQ:GIBO
|
HK |
|
China Railway Construction Corp Ltd
HKEX:1186
|
CN |
|
S
|
SNS Network Technology Bhd
KLSE:SNS
|
MY |
|
K
|
Kirkstone Metals Corp
OTC:KSMCF
|
CA |
|
Anhui Sierte Fertilizer Industry Ltd Co
SZSE:002538
|
CN |
|
Jinke Smart Services Group Co Ltd
HKEX:9666
|
CN |
|
I
|
Imugene Ltd
OTC:IUGNF
|
AU |
|
Magnite Inc
NASDAQ:MGNI
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (19.2), the stock would be worth $-0.01 (5 151% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.4 | $0 |
0%
|
| Industry Average | 19.2 | $-0.01 |
-5 151%
|
| Country Average | 19.6 | $-0.01 |
-5 249%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Nemaura Medical Inc
OTC:NMRD
|
3.3m USD | -0.4 | -0.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
177.7B USD | 21.4 | 27.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.7B USD | 52.3 | 56.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.1B USD | 24.2 | 39.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.7B USD | 19.4 | 24 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
92.8B USD | 25.5 | 32 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.1B USD | 26.4 | 44 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.6B EUR | 15.3 | 19.2 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46B USD | 34.1 | 43.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.2B USD | 16.8 | 25.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.8B USD | 17.2 | 22.1 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.6 |
| Median | 19.6 |
| 70th Percentile | 27.8 |
| Max | 1 826 183.2 |
Other Multiples
Nemaura Medical Inc
Glance View
Nemaura Medical, Inc. operates as a holding company. The company is headquartered in New York City, New York and currently employs 25 full-time employees. The company went IPO on 2014-11-04. The firm is focused on developing sugarBEAT, which is a non-invasive, glucose monitoring system, for use by persons with Type I and Type II diabetes and used to screen pre-diabetic patients. SugarBEAT consists of disposable adhesive skin-patch containing a sensor, which is connected to a rechargeable wireless transmitter.The SugarBEAT works by extracting glucose from the skin into a chamber in the patch that is in direct contact with an electrode-based sensor .The sensor takes a measurement of the glucose reading every five minutes and sends the data by low energy blue tooth to a smart device such as mobile phone (both android and iOS).The data is recorded on the app and can be viewed in real time as well as storing all historic data for later evaluation as desired. The firm's subsidiaries include Region Green Limited.
